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Background: G protein-coupled receptors (GPCRs) represent a physiologically and pharmacologically important
family of receptors that upon coupling to GαS stimulate cAMP production catalyzed by adenylyl cyclase. Thus,
developing assays to monitor cAMP production is crucial to screen for ligands in studies of GPCR signaling. Primary
cell cultures represent a more robust model than cell lines to study GPCR signaling since they physiologically
resemble the parent tissue. Current cAMP assays have two fundamental limitations: 1) absence of cAMP kinetics as
competition-based assays require cell lysis and measure only a single time-point, and 2) high variation with separate
samples needed to measure consecutive time points. The utility of real-time cAMP biosensors is also limited in
primary cell cultures due to their poor transfection efficiency, variable expression levels and inability to select stable
clones. We therefore, decided to develop an assay that can measure cAMP not only at a single time-point but the
entire cAMP kinetics after GPCR activation in untransfected primary cells.
Results: CANDLES (Cyclic AMP iNdirect Detection by Light Emission from Sensor cells) assay for monitoring cAMP
kinetics in cell cultures, particularly in primary cultures was developed. The assay requires co-culturing of primary
cells with sensor cells that stably express a luminescent cAMP sensor. Upon GPCR activation in primary cells, cAMP
is transferred to sensor cells via gap junction channels, thereby evoking a luminescent read-out. GPCR activation
using primary cultures of rat cortical neurons and mouse granulosa cells was measured. Kinetic responses of different
agonists to adrenergic receptors were also compared using rat cortical neurons. The assay optimization was done by
varying sensor-test cell ratio, using phosphodiesterase inhibitors and testing cell-cell contact requirement.
Conclusions: Here we present CANDLES assay based on co-culturing test cells with cAMP-detecting sensor cells.
This co-culture setup allows kinetic measurements, eliminates primary cell transfections and reduces variability. A
variety of cell types (rat cortical neurons, mouse granulosa cells and established cell lines) and receptors (adrenergic,
follicle stimulating hormone and luteinizing hormone/chorionic gonadotropin receptors) were tested for use with
CANDLES. The assay is best applied while comparing cAMP generation curves upon different drug treatments to
untransfected primary cells.
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G protein-coupled receptors (GPCRs) constitute the largest
family of cell surface receptors (>800 in humans), which
regulate a plethora of functions in multicellular organisms
owing to their diverse ligands that range from odors,
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unless otherwise stated.neurotransmitters to hormones [1,2]. This inherent di-
versity in ligand subtypes also leads to activation of
multiple cellular pathways both via G protein-dependent
(GαS, Gαi/o, Gαq/11, Gα12/13 and Gβγ) and independent
pathways [2-6]. One of the major pathways upon GPCR
activation acts via coupling to GαS protein thereby ac-
tivating adenylyl cyclase [7] that leads to conversion of
adenosine triphosphate (ATP) to the secondary messenger,
3′,5′-cyclic adenosine monophosphate (cAMP) [8-10].
Thus the detection of cAMP constitutes an important
readout for monitoring GPCR activation as well as for
screening for potential ligands to GPCRs.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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model over immortalized or transformed cell lines to
study GPCR signaling, since the former are physiolo-
gically closer to their parent tissue with respect to their
genetic integrity, receptor numbers, life span as well as
metabolic pathways and regulatory control [11-13].
Additionally, primary cell cultures are more appropriate
to study the function of a GPCR that is endogenously
expressed in the cells at physiological levels, rather
than the commonly employed method of exogenous
receptor over-expression in cell lines. One of the major
limitations of the frequently used assays for cAMP
detection, especially in primary cell cultures, is the
inability to kinetically monitor cAMP production, as
majority of the methods are competition assays that
require cell lysis, thus allowing only a single time-point
measurement (see Figure 1A for a representative colori-
metric competition assay) [14-18]. Moreover, to study the
magnitude of cAMP production at different time points
after GPCR activation, a different set of samples is needed,
which further adds to the variability among separate time
points, as has traditionally been done using immunoassays
[17,18].A.
C.
Figure 1 Principles of commonly used cAMP assays. (A) A colorimetric
incubation of anti-IgG antibody-coated plates with peroxidase labeled cAM
endogenous cAMP. Endogenous cAMP produced upon GPCR stimulation i
sites. After incubation and washing steps, cAMP-conjugate remaining in th
(B) FRET-based sensor design containing cAMP binding domain from eithe
and yellow fluorescent protein (YFP). In the absence of cAMP, there is FRET
leads a conformational change resulting in loss of FRET between CFP and
from either EPAC or PKA protein fused between Renilla luciferase (Rluc) and
generate light, part of which is transferred via resonance (BRET) to YFP. Bin
abolishing BRET between Rluc and YFP. (D) Design of GloSensor-22F cAMP se
subunit (RIIβB) is fused between N- and C-termini of a permuted firefly lucifer
domains of luciferase, which in the presence of its substrate (GloSensor cAMPRecently, the focus in designing cAMP assays has shifted
to the development of biosensor systems that can detect
cAMP generation in real time in living cells [19]. These
sensor proteins usually contain a cAMP-binding domain
based either on Protein Kinase A (PKA) [20] or Exchange
Protein Activated by cAMP (EPAC) [21] fused between
two fluorescence resonance energy transfer (FRET) [22-28]
or bioluminescence resonance energy transfer (BRET)
[29,30] pairs. Binding of cAMP to PKA or EPAC domain
causes a change in FRET or BRET ratio that evokes a live
readout of GPCR activity (Figure 1B and 1C). Another
useful system is the sensor (GloSensor-22F) that consists
of a cAMP-binding domain of PKA (RIIβB) fused between
the N- and C-termini of Photinus pyralis luciferase. Upon
cAMP binding to the PKA domain, a conformational
change allows the two domains of luciferase to attain a
functional conformation and thus to metabolize luciferin
(GloSensor cAMP reagent), giving a luminescent read-
out (Figure 1D) [31]. However, the application of these
methods to primary cell cultures is limited due to: (1)
difficulties associated with transfecting primary cells, (2)
the heterogeneous populations resulting from the variable
expression of these sensor systems, and (3) the inabilityB.
D.
competitive enzyme-linked immunosorbent assay (ELISA) involving
P (cAMP-conjugate), anti-cAMP antibody, and cell lysate containing
n cells competes with cAMP conjugate for anti-cAMP antibody binding
e well gives a colorimetric readout upon peroxidase substrate addition.
r PKA or EPAC protein fused between cyan fluorescent protein (CFP)
between CFP and YFP, whereas cAMP binding to the binding domain
YFP. (C) BRET-based sensor design containing cAMP binding domain
YFP. In the absence of cAMP, Rluc utilizes coelenterazine substrate to
ding of cAMP to the sensor causes a conformational change, thereby
nsor (adapted from [31]). cAMP-binding domain from PKA regulatory
ase. Binding of cAMP to RIIβB favors a conformational change in two
reagent) gives a luminescent read-out.
1. Generate cAMP Sensor cells (GS-293 or EPAC-293) 
    (HEK-293 + GloSensor-22F / TEPACVV)
2. Co-culture Sensor and Donor cells for 24-48 h




3. Replace DMEM complete medium with assay medium
4. Equilibrate cells for 45 min at room temperature (in dark)  
6. Measure basal luminescence / FRET
7. Add ligands and measure luminescence / FRET




Figure 2 CANDLES Assay protocol. The CANDLES assay involves
co-culture of sensor cells (GS-293 or EPAC-293) with donor cells
(primary cells or cell lines). DMEM complete medium is replaced
with freshly prepared assay medium and cells are pre-incubated
(in dark for GS-293 cells) before luminescence/ FRET measurements
can be read upon ligand stimulation.
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these sensors in primary cells is to use viral transfection
methods [32] (adeno-, lenti- or retroviruses) that require
at least biosafety level 2 (BSL-2) facilities and the need of
species-specific viruses (e.g. adenoviruses), yet points 2
and 3 still apply.
To overcome the aforementioned problems, we intro-
duce a new method for monitoring cAMP generation,
especially from primary cell cultures. Our method involves
generation of a separate stable sensor cell line that ex-
presses a cAMP sensor (GloSensor 22F) in co-culture
with the cells under study (expressing the GPCR whose
function is to be studied), thereby eliminating the need
to either transfect primary cells or to use a different set
of samples for different time points. GPCR stimulation
in the cells under study leads to cAMP generation,
which is then transferred to the co-cultured sensor
cells. The detection of cAMP by the sensor cells causes a
change in the conformation of the cAMP sensor protein,
which in the presence of a luciferin substrate gives a lumi-
nescent readout of GPCR activation-dependent activity
(Figure 1D). Since the assay involves indirect detection of
cAMP produced by the primary cells as a luminescent
readout by the co-cultured sensor cells, we named the
assay as the CANDLES (Cyclic AMP iNdirect Detection
by Light Emission from Sensor cells) assay.
Results
Proof of concept
Previous studies have shown that gap junction channels
[33-35], which serve as intercellular communication
channels between neighboring cells, allow transfer of
small molecules and metabolites (<1kDa) including cAMP
[36-40]. We thought of utilizing this property and hypoth-
esized that cAMP produced upon stimulation of GPCRs
in donor cells (primary cells or established cell lines) could
be detected by a separate sensor cell line (cAMP sensor
cells) if they are co-cultured (Figure 2).
Prior to isolating primary cells from animals, we first
tested two established cell lines with rarely expressed
GPCRs in donor cells: KK-1 cells [41] that endogenously
express luteinizing hormone/chorionic gonadotropin
receptor (LHCGR) and human embryonic kidney-293
(HEK-293) cells stably-transfected with human follicle-
stimulating hormone receptor (FSHR) [from here forward
referred to as FSHR-293]. The underlying concept behind
testing FSHR and LHCGR was that the donor cells ex-
press these receptors while the sensor cells do not.
We compared two different sensors, a luminescence
based sensor (GloSensor-22F) and a FRET based cAMP
sensor (TEPACVV) by stably transfecting these sensors in
HEK-293 cells, thereby generating two sensor cell lines,
GS-293 and EPAC-293, respectively (see Methods). HEK-
293 cells were chosen to generate sensor cells since theyexpress moderate levels of gap junctions [35,42]. We
tested if GS-293 or EPAC-293 cells could sense the
cAMP generated by FSHR-293 cells stimulated by
follicle-stimulating hormone (FSH). Since the cAMP
generated by donor cells is degraded by endogenous
phosphodiesterases, we used a non-specific phospho-
diesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX),
to prevent cAMP degradation. In the absence of IBMX,
GS-293 cells (Figure 3A) or EPAC-293 cells (Figure 3B)
cannot detect cAMP generated upon stimulation of
FSHR-293 cells with recombinant human (r) FSH (Merck-
Serono). Unstimulated co-cultures of sensor and donor
cells either in presence or absence of IBMX were used as
controls to observe the effect of IBMX alone. It is there-
fore crucial for this assay to use phosphodiesterase inhibi-
tor so that cAMP generated by donor cells will not be
degraded before the sensor cells can detect it. We then
tested different doses of IBMX, where 100 μM gener-
ated a better signal over background ratio (Additional
file 1: Figure S1) and thus was used for all further
experiments.
As expected, both sensor cell lines were able to detect
cAMP generated from co-cultured FSHR-293 cells upon
stimulation with rFSH (Figure 3A and 3B). However, we
chose the luminescent sensor cells (GS-293) over the
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C. GS-293 and KK-1 co-culture
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B. EPAC-293 and FSHR-293 co-culture
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D. Absence of LHCGR expression 
in GS-293 cells
GS-293 and KK-1 rLH
GS-293 Unstimulated
GS-293 and KK-1 Unstimulated
GS-293 rLH
rLH
Figure 3 Detection of cAMP generated by donor cells using sensor cells. (A) Preincubation of co-cultures of GS-293 (50,000 cells) with
FSHR-293 (50,000 cells) for 45 minutes with assay medium either in the presence or absence of IBMX and monitoring luminescence after addition
of rFSH (200 mIU/ml). GS-293 cells could detect cAMP production upon stimulation of FSHR-293 cells with rFSH only in the presence of IBMX. In the
absence of IBMX, no luminescent signal upon FSHR-293 stimulation could be detected. Data represented as mean of triplicates for one representative
experiment ± standard error of the mean (SEM). (B) EPAC-293 and FSHR-293 co-cultures (50,000 cells each) were stimulated with rFSH (200
mIU/ml) in the presence or absence of IBMX. A change in FRET ratio (480/528 nm) was observed after rFSH stimulation. EPAC-293 cells could
detect cAMP production from co-cultured FSHR-293 cells only in the presence of IBMX. Data represented as mean of triplicates for one
representative experiment (± SEM). (C) Co-culture of GS-293 (25,000 cells) with KK-1 (75,000 cells) and monitoring luminescence after addition of rLH
(100 ng/ml). Data represented as mean of triplicates for one representative experiment (± SEM). (D and E) Absence of LHCGR and FSHR expression in
GS-293 cells is shown by luminescence values upon rLH (100 ng/ml) and rFSH (200 mIU/ml) stimulation being similar to unstimulated GS-293 control.
Stimulated co-culture of GS-293 cells with either KK-1 or FSHR-293 cells was used as positive control for LHCGR and FSHR expression, respectively.
Unstimulated co-cultures of GS-293 with either KK-1 or FSHR-293 were used as negative control. Data represented as mean of duplicates for
one representative experiment [± standard deviation (SD)]. All the experiments have been independently repeated at least three times.
(Relative Light Unit: RLU).
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ments since we could not detect a dose-dependent change
in FRET ratio with the EPAC-293 sensor cells when the
co-cultured FSHR-293 cells were stimulated with increas-
ing doses of rFSH (Additional file 2: Figure S2). Moreover,
luminescence measurements were not associated with
photobleaching of the sensor and thereby did not require
additional normalization controls.
We then tested a cell line, KK-1 cells, which expresses
an endogenous GPCR, in this case the LHCGR. As
shown in Figure 3C upon stimulation with recombinant
luteinizing hormone (rLH), the GS-293 cells were able
to detect the cAMP generation of neighboring KK-1
cells. Unstimulated co-culture of GS-293 and KK-1 cells
as well as GS-293 cells cultured alone were used as con-
trols. GS-293 cells did not respond to either ligand when
cultured alone (Figure 3D and 3E).
Optimizing the ratio of sensor cells to donor cells
To find the optimal conditions for detecting high
cAMP signal, we first kept the number of sensor cells
(GS-293) constant and increased the number of donor
cells (KK-1 or FSHR-293) in increasing ratios (sensor
cells: donor cells in increasing ratio from 1:1 to 1:4).
As expected, cAMP signal detected by GS-293 cells in-
creased with increasing ratio of donor cells (Figures 4A
and 4B). Moreover, beyond a ratio of 1:3 of sensor to
donor cells, the proportionate increase in luminescent
signal was less marked, and hence the optimal starting
sensor to donor cell ratio for using this method for
other cell types and receptors was considered to be
around 1:3.
However, when we increased the number of sensor
cells (GS-293) and kept the number of donor cells
(FSHR-293) constant, we observed that cAMP detection
via GS-293 cells decreased as the number of GS-293
cells increased (Figure 4C) upon stimulation of cells with
rFSH (200 mIU/ml). This is likely due to decreasing
number of cell-cell contacts between donor and sensor
cells as an increasing number of sensor cells facilitate more
cell-cell contacts among themselves than between sensor
and donor cells. Hence increasing the number of sensor
cells may not increase the luminescent read-out. Un-
stimulated co-culture of GS-293 with either KK-1 cells
or FSHR-293 cells as well as GS-293 cells cultured alone
were used as controls for all the aforementioned experi-
ments showing no cAMP responses.
Cell-to-cell contact is needed for cAMP detection
We had so far co-cultured sensor and donor cells in the
same well such that both cell types have cell-cell contacts.
To further test whether a decreasing number of cell-cell
contacts between sensor and donor cells was responsible
for a decrease in signal as shown in Figure 4C, we testedthe effect of complete abolition of contacts between
the sensor and donor cells. To this end, we cultured
FSHR-293 and GS-293 cells in isolation using 24-well
permeable support transwells (containing pores of 0.4
μm for diffusion of molecules) in DMEM complete
medium (Figure 5A). After a one-day culture, DMEM
complete medium was discarded. 300 μl of assay medium
was added to FSHR-293 cells, and GS-293 cells growing
in transwell permeable support were placed on top of the
FSHR-293 wells. Finally 100 μl of assay medium was also
added on top of transwell permeable supports. The porous
membrane ensures that the cells can still interact in a
paracrine fashion through the medium rinsing both
cell types. The cells were then stimulated with rFSH
(200 mIU/ml) and compared with stimulation of GS-293
cells and FSHR-293 cells with rFSH that were co-cultured
with cell-cell contacts. The data in Figure 5B shows that
cell-cell contact is necessary for detection of cAMP by
GS-293 cells. Separation of GS-293 and FSHR-293 cells
with transwell permeable support leads to loss of cAMP
detection by GS-293 cells, comparable to unstimulated
control (GS-293) cells.
To test whether the permeable membrane could allow
the movement of small molecules, or even large glycopro-
tein hormones like rFSH, FSHR-293 and GS-293 were
co-cultured in transwell chamber (15,000 cells each)
for 48 hours. The cells were similarly tested in assay
medium and rFSH was added in either the top chamber
or the bottom well. Figure 5C shows that cAMP signal
from FSHR-293 cells could be detected by GS-293
cells, the only difference being stimulation in top chamber
(containing 100 μl of assay medium) was more pro-
nounced than in the bottom well (containing 300 μl of
assay medium) due to differences in effective concentra-
tion of the hormone in the two chambers. Unstimulated
co-culture of FSHR-293 with GS-293 cells was used as
negative control.
Gap junction channels mediate cAMP transfer from donor
to sensor cells
To further explore the molecular components of cell-
to-cell contact that were responsible for transfer of
cAMP from donor to sensor cells, we tested the role of
gap junctions. Carbenoxolone (CBX), a gap junction
inhibitor [43,44], was added to co-cultures of GS-293 and
FSHR-293 cells (Figure 6A). GS-293 and FSHR-293 co-
cultures were preincubated for 1h with different doses of
CBX in assay medium, followed by stimulation with rFSH
(200 mIU/ml). Figure 6A shows a dose–dependent de-
crease in luminescence from the sensor cells, while the
lowest dose (25 μM) resulted in similar values to positive
control (GS-293 and FSHR-293 co-culture without
CBX and stimulated with rFSH), the highest CBX dose
(100 μM) completely abolished cAMP detection as the





















A. GS-293 and KK-1 co-culture
GS-293 : KK-1 (1:3) rLH
GS-293 : KK-1 (1:4) rLH
GS-293 Unstimulated
GS-293 and KK-1 Unstimulated
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C. FSHR-293 and GS-293 co-culture
FSHR-293 : GS-293 (1:1) rFSH
rFSH
FSHR-293 : GS-293 (1:2) rFSH
FSHR-293 : GS-293 (1:3) rFSH
FSHR-293 : GS-293 (1:4) rFSH
GS-293 Unstimulated
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B. GS-293 and FSHR-293 co-culture
GS-293 : FSHR-293 (1:1) rFSH
GS-293 : FSHR-293 (1:2) rFSH
GS-293 : FSHR-293 (1:3) rFSH
rFSH
GS-293 Unstimulated
GS-293 and FSHR-293 Unstimulated
GS-293 : FSHR-293 (1:4) rFSH
Figure 4 Optimization of the ratio of sensor (GS-293) to donor cells for maximal luminescence (cAMP generation). (A) Cell seeding
density of GS-293 cells: KK-1 cells in increasing ratio from 1:1 to 1:4 (25,000 cells of each for 1:1 ratio). (B) Cell seeding density of GS-293: FSHR-293
cells in increasing ratio from 1:1 to 1:4 (25,000 cells of each for 1:1 ratio). (A and B) An increased luminescent signal [proportional to cAMP production
upon rLH (100 ng/ml) or rFSH (200 mIU/ml) stimulation] was detected with increasing number of donor cells (KK-1 or FSHR-293). (C) Cell
seeding density of FSHR-293: GS-293 cells in increasing ratios from 1:1 to 1:4 (25,000 cells of each for 1:1 ratio) and a decrease in luminescent
signal was observed for an increasing number of GS-293 cells. (A, B and C) Data represented as mean of triplicates for one representative
experiment (± SEM; positive direction) with at least three independent repeats.
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control (GS-293) cells.
In order to eliminate that the effect was due to cyto-
toxicity upon CBX treatment, cell viability was assessed 2h
post-CBX treatment. As shown in Figure 6B, CBX treat-
ment did not alter cell viability and the dose-dependent
decrease in luminescent signal as seen in Figure 6A cannot
be attributed to cell death.
To further examine whether the drop in luminescence in
Figure 6A was only due to inhibition of cAMP transfer and
not due to decrease in cAMP production, we first assessed
the absolute cAMP concentrations after stimulation ofGS-293 and FSHR-293 co-cultures via a cAMP enzyme-
linked immunosorbent assay (ELISA) kit. GS-293 and
FSHR-293 cells were co-cultured in 6-well plates. Prior to
ELISA, cells were incubated with different concentrations
of CBX in assay medium (without GloSensor cAMP re-
agent) for 1h at room temp and subsequently stimulated
with rFSH (200 mIU/ml) for 20 min. Cells were lysed and
cAMP concentrations were determined according to manu-
facturer’s instructions. GS-293 and FSHR-293 co-cultures
incubated in assay medium (without CBX and GloSensor
cAMP reagent) were used as controls. Figure 6C shows that




























B. GS-293 and FSHR-293 co-culture 
with or without cell-cell contact
Cell-Cell contact rFSH 
No Cell-Cell contact rFSH 
Control Unstimulated 
rFSH


















C. FSHR-293 and GS-293 co-culture
in top transwell support
GS-293 + FSHR-293 (rFSH in Upper chamber)
GS-293 + FSHR-293 (rFSH in Bottom well)
GS-293 + FSHR-293 Control Unstimulated
rFSH
Figure 5 GS-293 cells require cell-cell contact to detect cAMP from donor cells. (A) GS-293 cells were grown on transwell permeable
supports and FSHR-293 cells were grown on the bottom of a separate well. Prior to experiment, the transwell chamber with the GS-293 cells was placed
above the FSHR-293 cells and medium was replaced with assay medium (referred to as ′No cell-cell contact” configuration). GS-293 and FSHR-293 cells
were also co-cultured in the transwell permeable support wells (referred to as “Cell-Cell contact” configuration). (B) In “No cell-cell contact” configuration,
GS-293 cells were unable to detect cAMP production from FSHR-293 cells stimulated with rFSH (200 mIU/ml) and the luminescent signal detected was
comparable to unstimulated GS-293 cells (control). The cell-cell contact configuration however yielded much higher luminescence, proving the
detection of cAMP by GS-293 cells from donor cells requires cell-cell contact. (C) In cell-cell contact configuration, rFSH stimulation in the upper
chamber yielded a higher response than rFSH stimulation in the bottom well due to higher effective concentration of rFSH in the former. (B and C)
Data represented as mean of duplicates for one representative experiment (± SD; positive direction) with at least three independent repeats.
Trehan et al. Cell Communication and Signaling 2014, 12:70 Page 7 of 17
http://www.biosignaling.com/content/12/1/70similar (for 25 μM and 50 μM CBX) or higher (for 75 μM
and 100 μM CBX) to the stimulated (rFSH) control. The
observed increase in cAMP at higher CBX doses might
be due to blockage of the physiological mechanism of
cAMP transfer to the neighboring cells and leakage to
the cell culture medium, thereby causing higher retention
of cAMP in treated cells. This suggests that the drop in
signal observed in Figure 6A was not due to a decrease in
cAMP production but rather due to inhibition of cAMP
transfer via gap junctions.
Since cAMP ELISA can determine only a terminal time
point, we decided to use our sensor GS-293 cells stably
transfected with human FSHR (hereby called GS-293-
FSHR cells) to determine the effect of CBX on cAMP
production in the same cells containing both the receptor
and the sensor with kinetics mode. Figure 6D shows no
significant changes in cAMP generation in the presence of
CBX. As in Figure 6C, higher doses of CBX have a
tendency to moderately increase cAMP production. This
further supports that cAMP production is not reduced
upon CBX treatment. All these observations point to the
conclusion that it is indeed the blockage of cAMP transferfrom donor to sensor cells upon inhibition of gap junction
communication that caused a dose-dependent reduction
of luminescent signal (Figure 6A).
To further confirm whether gap junction channels,
which are composed of connexin proteins, were respon-
sible for cAMP transfer from donor to senor cells, co-
cultures of FSHR-293 and GS-293 cells were transiently
transfected with increasing amounts of human connexin-
32 (Cx32) plasmid. The total amount of transfected DNA
was kept constant at 0.75 μg DNA/well by addition of
pcDNA3.1 mock plasmid. The expression of Cx32
(fluorescently tagged with mEmerald) was verified by
using EVOS fluorescent microscope (Additional file 3:
Figure S3). Figure 6E shows that overexpressing Cx32
increases the cAMP detection by the sensor cells as
compared with mock-transfected cells (control). The
increase in cAMP transfer is statistically significant to
control (p-value =0.0017) as calculated by comparing
the area under curve of luminescence values for different
samples using one-way analysis of variance (ANOVA).
The area under curve (in arbitrary units ± SEM) for dif-
ferent samples was Cx32 (0.75 μg): 384000 ± 5400, Cx32
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B. Cell Viability (2h post-CBX treatment)
GS-293 and FSHR-293 coculture  






















CBX (100 M) rFSH
CBX (75 M) rFSH
CBX (50 M) rFSH
CBX (25 M) rFSH
Control Unstimulated
rFSH
Figure 6 (See legend on next page.)
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Figure 6 Gap junctions mediate transfer of cAMP from donor to sensor cells. (A) CBX (25, 50, 75 and 100 μM) preincubated co-cultures of
GS-293 with FSHR-293 (50,000 cells each) were stimulated with rFSH (200 mIU/ml). Increasing doses of CBX lead to decreasing luminescence, with
100 μM CBX reducing the luminescence to levels similar to unstimulated GS-293 control cells. Data represented as mean of triplicates for one
representative experiment ± SEM (positive direction only) with at least three independent repeats. (B) GS-293 and FSHR-293 co-cultures (50,000
cells each) were incubated with CBX (25, 50, 75 and 100 μM) for 2h in assay medium while the control samples had only assay medium without
CBX. Cell viability 2h post-CBX treatment shows no statistical difference among samples using one-way ANOVA (p-value =0.9891). (C) Total cAMP
concentration in co-cultures of GS-293 and FSHR-293 (150,000 cells each) as assessed by ELISA following stimulation with rFSH (200 mIU/ml) for
20 min. Total cAMP concentration in cells treated with 75 μM and 100 μM CBX was higher (p < 0.0001) than stimulated control while those with
25 μM and 50 μM CBX are similar to the stimulated control. (D) rFSH (200 mIU/ml) stimulation of GS-293-FSHR (50,000 cells) preincubated with
higher doses of CBX (50, 75 and 100 μM) moderately increased cAMP production as compared to GS-293-FSHR control cells (preincubated with
assay medium without CBX). (E) Co-cultures of GS-293 and FSHR-293 were transfected with increasing amounts of Cx32 plasmid. Co-culture of
FSHR-293 and GS-293 transfected with pcDNA3.1 mock plasmid was used as control. Cx32 expression lead to a statistically significant (p-value =0.0017)
increase in detection of cAMP by the sensor cells as compared to control stimulated cells. (B, C, D and E) Data represented as mean of triplicates for
one representative experiment (± SEM) with at least three independent repeats.
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279000 ± 16000. Thus we conclude that the mechanism
of transfer of cAMP from donor cells to sensor cells is
mediated via gap junctions.
Dose-dependent detection of cAMP from donor cells by
GS-293 sensor cells
We also tested whether the amount of luminescent sig-
nal generated by GS-293 cells follows an expected dose-
dependent increase when we stimulate the co-cultured
donor cells (FSHR-293) with increasing amounts of rFSH.
Figure 7A shows that the GS-293 response indeed is
proportional to the increase in cAMP production from
FSHR-293 cells following stimulation with different
doses of rFSH. Unstimulated FSHR-293 and GS-293
co-culture was used as control. The adjoining table in
Figure 7A also shows the area under curve (in arbitrary
units) for the luminescence values detected at different
rFSH concentrations. EC50 values were calculated from
luminescence (Relative Light Unit: RLU) using a single
time point, at 20 min after FSH stimulation, and com-
pared with EC50 values calculated using a traditional
cAMP ELISA kit of FSHR-293 cells grown in 6-well
plates and stimulated with increasing doses of rFSH for 20
min. As shown in Figure 7B, EC50 values from CANDLES
assay (123.6 mIU/ml) are comparable to those calculated
using cAMP ELISA kit (115.6 mIU/ml).
Detection of cAMP production from primary cell cultures
GS-293 cells were co-cultured with two completely dif-
ferent primary cell types (mouse granulosa cells and
rat cortical neurons) in order to test our method for a
variety of cell-specific receptors. Granulosa cells endogen-
ously express LHCGR and we selected rat cortical neurons
as a blind test and therefore tested them for the expres-
sion of adrenergic receptors and glutamate receptors.
Figure 8A depicts that stimulation of granulosa cells
with rLH (100 ng/ml) resulted in stimulation of LHCGR
and the downstream generation of cAMP, which in turnwas detected by GS-293 cells. Similarly, the stimulation
of rat cortical neurons (Figure 8B) by epinephrine showed
the presence of adrenergic receptors whereas the stimu-
lation by glutamate resulted in no detectable responses.
Unstimulated co-cultures of GS-293 with either granulosa
cells or neurons were used as negative controls. The above
experiments confirm the utility of our method in kin-
etic measurements of cAMP production in primary cell
cultures.
CANDLES assay was also used to compare the kinetics
of different agonists for adrenergic receptors in rat cortical
neurons (Figure 8C). Epinephrine was used as a non-
selective agonist for α1, α2, β1 and β2 adrenergic recep-
tor activation, and isoproterenol selectively activates β1
and β2 adrenergic receptors, while salbutamol activates
only β2 adrenergic receptors. Although epinephrine,
isoproterenol and salbutamol also stimulated GS-293
cells alone (Figure 8D), confirming the presence of en-
dogenous adrenergic receptors in GS-293 cells, the signal
(luminescence) was very low in comparison to what was
observed for cortical neurons (compare Y-axes in Figures 8C
and 8D). Hence, the GS-293 cells could still be used as
sensor cells. Unstimulated co-culture of GS-293 with
neurons and GS-293 cells cultured alone were used as
negative controls.
Adapting GS-293 cells from DMEM/F12 medium to other
commonly used media
GS-293 cells have so far been grown in DMEM/F12
medium. To ensure proper growth conditions of the
sensor cells in co-cultures with different kind of cells
growing in their own respective medium, we chose to
adapt sensor cells in two of the most commonly used
cell culture media; McCoy’s 5A and RPMI 1640. First,
GS-293 cells were grown in medium containing 20%
McCoy’s 5A and 80% DMEM/F12 medium for one week.
In the successive weeks the concentration of McCoy’s 5A
medium was increased to 40, 60, 80 and 100%. Similarly,
GS-293 cells were also adapted in RPMI 1640 medium.






















A. FSHR-293 and GS-293 co-culture
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Figure 7 Comparison of dose-response curves derived using CANDLES or cAMP ELISA. (A) An increasing stimulation of FSHR-293 (50,000
cells) with rFSH (0.01 mIU/ml to 1000 mIU/ml) also yields a dose-dependent increase in luminescent signal from co-cultured GS-293 (50,000 cells).
The adjoining table shows the area under curve of luminescence values for different rFSH doses. (B) Luminescence values (RLU) in Figure 7A (20
min after stimulation) were used to calculate EC50 for CANDLES (123.6 mIU/ml). A cAMP ELISA kit was used to compare EC50 values with CANDLES.
FSHR-293 cells (150,000 cells) stimulated with similar doses of rFSH (0.1 mIU/ml to 1000 mIU/ml) for 20 min were used to calculate cAMP values
using ELISA. Data were normalized to percentage of maximal responses and curves were fitted using four-parameter logistic curve. EC50 values
calculated using CANDLES (123.6 mIU/ml) are very similar to those calculated using a cAMP ELISA kit (115.6 mIU/ml) and there is no statistical
difference (p = 0.9885). (A and B) Data represented as mean of triplicates for one representative experiment (± SEM) with at least three
independent repeats.
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5A and RPMI 1640 media. CANDLES assay was then
performed with co-cultures of GS-293 and FSHR-293
cells adapted in either 100% McCoy’s 5A medium or
100% RPMI 1640 medium. The assay medium was
modified to contain a 1:1 ratio of CO2-independent
medium with either McCoy’s 5A medium or RPMI 1640
medium. As shown in Figures 9A and 9B, sensor cells
could be easily adapted to different media, thereby ensur-
ing optimal growth conditions to that of the donor cell
type of choice and hence can follow cAMP production
upon stimulation of co-cultured donor cells. Unstimulated
co-culture of GS-293 with FSHR-293 cells as well as GS-
293 cells cultured alone were used as controls.
Comparison of cAMP accumulation using CANDLES with
real-time cAMP production
The CANDLES assay measures cAMP accumulation
over a period of time due to addition of non-specificphosphodiesterase inhibitor, IBMX. Therefore, the shape
of the luminescence curve reveals cAMP accumulation
over time rather than instantaneous cAMP production.
We used GS-293 cells stably transfected with the LHCGR
(GS-293-LHCGR) to obtain instantaneous cAMP kinetics
after rLH (100 ng/ml) stimulation (Figure 10; right Y-axis,
red line) in assay medium without IBMX. GS-293 cells
co-cultured with KK-1 cells (natively expressing LHCGR)
were used to obtain cAMP accumulation curve using
CANDLES assay (Figure 10; left Y-axis, black line). As
shown in Figure 10, cAMP accumulation saturates after
apparent LHCGR desensitization.
Discussion
The coupling of many GPCRs upon ligand activation to
GαS leads to activation of adenylyl cyclase that catalyzes
the production of cAMP [9,10]. Given the massive import-
ance of GPCR signaling in pharmacology, many cAMP
assays for screening ligands as well as to study the GPCR
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Figure 8 Monitoring cAMP generation in primary cells with GS-293 cells. (A) Mouse granulosa cells were co-cultured with GS-293 (100,000
cells). GS-293 detected cAMP generated by rLH (100 ng/ml) stimulation of LHCGR in granulosa cells. (B) Rat cortical neurons were co-cultured
with GS-293 (100,000 cells) and stimulated with epinephrine or glutamate. Epinephrine led to generation of cAMP, while glutamate resulted in no
response. (A and B) Data represented as mean of duplicates for one representative experiment (± SD) with at least three independent repeats.
(C) Rat cortical neurons were co-cultured with GS-293 (100,000 cells) and stimulated with isoproterenol (100 nM), epinephrine (100 nM) and salbutamol
(100 nM) to compare their different kinetic responses upon stimulation of adrenergic receptors. (D) GS-293 cells also express adrenergic receptors as
can be seen in response to isoproterenol, epinephrine and salbutamol stimulation, although the response to stimulation is minimal in comparison to
cortical neurons (compare the Y-axis with Figure 8C). (C and D) Data represented as mean of triplicates for one representative experiment (± SEM)
with at least three independent repeats.
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http://www.biosignaling.com/content/12/1/70signaling have been designed. There are many model sys-
tems in which GPCR signaling can be studied, ranging
from in vivo mouse models to in vitro cell culture systems
using established cell lines (transformed or immortalized).
Primary cell cultures using freshly isolated tissues from
animal models or clinical samples represent a biologically
relevant system to study GPCR signaling over immortal-
ized or transformed cell lines, since the former retain most
of their physiological functions and regulatory controls.
However, the currently available methods for monitoring
cAMP production, especially on primary cells, suffer from
two major drawbacks. First, their inability to measure the
kinetics of cAMP production since the majority of them
are competition-based and hence require cell lysis afterligand stimulation to measure intracellular cAMP, thereby
measuring only one single time-point. Second, it is diffi-
cult to transfect primary cells by most methods (except
viral transfections) with new fluorescent or luminescent
cAMP sensor encoding plasmids, which can ideally meas-
ure cAMP kinetics. Although viral transfections are highly
efficient, they are labor-intensive, require special safety
regulations and might only infect species-specific cells
(e.g. adenoviruses), something that our assay does not
require as mouse, rat and human cells were used in our
studies.
Our CANDLES assay is able to kinetically monitor cAMP
production in primary cell cultures upon specific GPCR
stimulation by co-culturing them with the cAMP-sensor




















A. GS-293 and FSHR-293 co-culture 
McCoy's 5A medium
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B. GS-293 and FSHR-293 co-culture
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Figure 9 Adapting GS-293 cells to grow in RPMI 1640 and McCoy’s 5A media. Both GS-293 and FSHR-293 cells were step-wise
adapted to grow in either McCoy’s 5A or RPMI 1640 media. After adapting cells, co-cultures of GS-293 (50,000 cells) and FSHR-293
(50,000 cells) were grown in either medium. (A and B) The CANDLES assay, performed after adapting the cells, can detect cAMP
from co-cultured donor cells. Data represented as mean of triplicates for one representative experiment (± SEM) with at least three
independent repeats.
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http://www.biosignaling.com/content/12/1/70cells (GS-293/ EPAC-293). The proof of concept for such
a system was established by initially using co-cultures of
sensor cells with donor cell lines: KK-1 and FSHR-293,
which express LHCGR and FSHR, respectively. The
stimulation of LHCGR and FSHR by their respective li-
gands, LH and FSH, led to production of cAMP that
was detected by the sensor cells (GS-293 or EPAC-203),
leading to a luminescent/FRET read-out only in the
presence of a phosphodiesterase inhibitor. Moreover,
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Figure 10 Comparison of kinetics of cAMP generation using
CANDLES with instantaneous cAMP production. cAMP accumulation
detected by GS-293 (25,000 cells) upon stimulation of co-cultured
KK-1 (75,000 cells) with rLH (100 ng/ml) (black line, left Y-axis) using
CANDLES. GS-293 cells stably transfected with a plasmid carrying
the Lhcgr cDNA (GS-293-LHCGR) and stimulated with rLH (100 ng/ml)
depicts real-time cAMP present in the cells (red line, right Y-axis).the assay medium contains IBMX and therefore cannot
follow the desensitization process, since phosphodiester-
ases that are responsible for lowering the cAMP concen-
tration in the cells are inhibited. Although 100 μM IBMX
was used in CANDLES assay, higher concentrations of
IBMX (200 μM) can also be used for low responding cells
yet the background will also increase (Additional file 1:
Figure S1). It was also established that the increase in
luminescent signal from GS-293 cells is directly propor-
tional to the number of donor cells and a 1:3 ratio of
GS-293 cells to donor cells provides an optimal signal
and can be used as a starting point for optimization of
the sensor to donor cell ratios for other cell types. How-
ever, increasing the amount of sensor cells does not lead
to increase in signal, rather it leads to a decrease in the
overall luminescent signal, possibly as the number of
cell-to-cell contact points between sensor and donor
cells is reduced. Finally we tested the utility of this
method in detecting cAMP production using two different
primary cell cultures from rat cortical neurons and mouse
granulosa cells. Moreover, fast kinetics of different
agonists can easily be compared as was shown for iso-
proterenol, salbutamol and epinephrine stimulation of
cortical neurons (note the duration of sharp peak in
Figure 8C) that would otherwise be extremely difficult
to compare by using competition-based assays.
For transferring of cAMP produced by the donor cells,
cell-cell contact is essential as was demonstrated by the
lack of luminescent signal generation upon physically
separating the GS-293 from FSHR-293 cells, using perme-
able porous transwell chambers. The molecular compo-
nents responsible for the transfer of cAMP were found to
be gap junction channels. This was established from five
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inhibitor, CBX, to co-cultures of GS-293 and FSHR-293
cells results in a decrease of the luminescent signal
from GS-293 cells, after stimulation with rFSH, in a
dose-dependent manner (Figure 6A). Second, this ob-
served drop in luminescence could not be attributed to
cytotoxicity, as incubation with CBX has no effect on
cell viability. Third, when absolute cAMP concentrations
in CBX-treated co-cultures of GS-293 and FSHR-293 cells
were calculated after rFSH stimulation, it was found that
cAMP production either remained similar (at lower CBX
doses) or was increased (at higher CBX doses) in compari-
son to control co-cultures (without CBX treatment),
thereby eliminating the possibility of a reduction in cAMP
production. The apparent increase in cAMP following
CBX treatment might be due to blockage of cAMP trans-
fer to the neighboring cells and the cell culture medium,
which usually happens in physiological conditions thereby
causing the cell lysates to retain higher cAMP concentra-
tion. Equivalently, the entire kinetics of cAMP production
upon CBX treatment followed in GS-293-FSHR cells
(expressing both the receptor and the cAMP sensor)
shows no significant changes in cAMP production after
CBX addition. Thus the application of gap junction in-
hibitor in co-cultures of sensor and donor cells did not
lead to a decrease in cAMP production but rather
caused a blockage of transfer of cAMP from donor to
sensor cells, thereby demonstrating that gap junction
channels are responsible for transfer of cAMP in CAN-
DLES assay. Finally, the overexpression of gap junction
protein (Cx32) leads to an increase in cAMP detection
by the sensor cells, thereby suggesting that gap junction
channels are responsible for transfer of cAMP in CAN-
DLES assay.
One of the major advantages of this method is the abil-
ity to kinetically monitor cAMP production, especially in
primary cell cultures that are otherwise difficult to trans-
fect and analyze with fluorescent or luminescent cAMP
sensors available at present [19,22,28,29,31]. We therefore
decided to generate separate biosensor cell lines express-
ing either a luminescent cAMP sensor (GloSensor 22F) or
a FRET-based cAMP sensor (TEPACVV). The luminescent
sensor was chosen over FRET-based sensors to avoid is-
sues relating to photobleaching, the requirement of a
more complex plate-reader (and/or microscopes) and the
need for extensive normalization controls. Moreover, the
dose-response of a FRET based cAMP sensor (TEPACVV)
generated very similar changes in FRET ratio, making it
difficult to compare the cAMP production in FSHR-293
cells stimulated with different doses of rFSH (Additional
file 2: Figure S2). The application of a separate sensor cell
line also solves the problem of high variability because
of the use of different cell samples that are needed for
multiple time-point measurements using competitionbased cAMP assays that require cell lysis. As this assay can
measure cAMP production from endogenous receptors
expressed in primary cell cultures, the response upon
GPCR stimulation can be considered to be physiologically
more relevant. Moreover, a dose-dependent response can
be measured, which shows the specificity of the assay.
CANDLES can also be used as a quick screening method
to ascertain the expression of functional GαS-coupling
GPCRs in cell types that have been in cell culture for a
prolonged duration, or to verify the identity and cross-
contamination of cells with a different cell type, as recently
reported in many laboratories [45].
One of the limitations of the assay is that the cells have
to be equilibrated with the GloSensor cAMP reagent prior
to stimulation of cells. This only allows multiple stimula-
tions (with different drugs) of the cells to be in the same
assay medium. However, this issue is common to all
luminescence-based sensors, not CANDLES in particular.
In addition, this assay cannot determine the absolute con-
centration of cAMP in the samples, and immunoassays
still remain the method of choice if the aim is to deter-
mine absolute cAMP concentrations with high sensitivity.
Nevertheless, EC50 values calculated using CANDLES
assay are similar to those using ELISA. However, there is a
possibility that some cell types may not form cell-cell con-
tacts with sensor cells. Hence the applicability of different
donor cells for the use with CANDLES has to be empiric-
ally determined.
Conclusion
CANDLES obviate the limitations imposed by current
cAMP assays that either cannot measure kinetics or re-
quires inefficient cell transfections with cAMP sensors.
The CANDLES assay is an easy and quick method to
indirectly follow the entire cAMP generation curves
from a variety of cell types including untransfected
primary cells as well as from different receptors (LHCGR,
FSHR, adrenergic receptors). Since assay measurements
at room temperature (25-28°C) give the best signal-to-
noise ratio (Additional file 4: Figure S4), only a single
luminescent plate-reader is required, and sophisticated
humidified gas chambers for live cell measurements are
unnecessary. The assay is highly robust and measure-
ments can easily be read for up to 2 hours. In addition,
sensor cells can be adapted to grow in different cell
culture media (DMEM/F12, RPMI-1640, McCoy’s 5A) en-
suring proper growth conditions for further co-incubation
with the primary cells of choice. Finally, the assay works
for cells of different origins, for example primary cultured
neurons from rats, granulosa cells from mice as well as
human cells. The major advantage of this assay lies in
experiments where monitoring the kinetics of cAMP
production upon GPCR activation or following different
cell stimuli is needed.
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Cell culture
Human embryonic kidney-293 (HEK-293) cells were ob-
tained from ATCC and KK-1 cell line (mouse granulosa
cell line) was developed in our laboratory [41]. Cell lines
were cultured in Dulbecco’s Modified Eagle Medium
(DMEM)/F12 media (Gibco) supplemented with 10%
fetal calf serum (FCS; PromoCell), 50 IU/ml penicillin
and 50 μg/ml streptomycin (hereafter referred to as
DMEM complete medium) and grown at 37°C in humidi-
fied atmosphere with 5% CO2. Cells (FSHR-293 and
GS-293; see below) were adapted from DMEM complete
medium to grow in RPMI 1640 or McCoy’s 5A media
(Gibco) supplemented with 10% FCS, 50 IU/ml penicillin
and 50 μg/ml streptomycin.
Assay medium for luminescence measurements
Prior to experiments, cell culture medium was replaced
with a freshly prepared assay medium. The assay medium
was formulated with CO2-independent medium (Invitro-
gen), DMEM/F12, GloSensor cAMP reagent (Promega),
3-Isobutyl-1-methylxanthine (IBMX; Sigma) and Bovine
serum albumin (BSA; Gibco). The assay medium contained
a 1:1 ratio of DMEM/F12 (0.1% BSA) and CO2-independ-
ent media (0.1% BSA) supplemented with 2% GloSensor
cAMP reagent and 100 μM IBMX.
Generation of the stable luminescent cAMP-sensor
(GS-293) cell line
HEK-293 cells in 6-well plates (3 × 105 cells) were trans-
fected with pGloSensor-22F cAMP plasmid (Promega)
[31] using JetPEI transfection reagent (Polyplus transfec-
tion). The cells carrying the pGloSensor-22F plasmid
were selected with hygromycin (200 μg/ml) in DMEM
complete media. Following hygromycin selection, the
selected clones were seeded in 96-well plates and grown
until confluence, followed by testing for maximal lumines-
cence after addition of 10 μM forskolin (LC laboratories,
USA) in assay media without IBMX. This was repeated
few times to select clones with highest response to cAMP
generation. The best clones were then selected for three
criteria: 1) highest luminescence upon addition of 10 μM
forskolin; 2) low and consistent basal luminescence; and
3) consistent signal with serial passages. The final clone
after four rounds of selection was subsequently named as
HEK293-GloSensor (GS-293) and was used for all further
experiments.
Assay methodology with GS-293 sensor cells
GS-293 cells were co-cultured with other cells express-
ing the receptor under study (primary cell cultures or
established cell lines) in either 12- or 24-well plates in
DMEM complete medium for 24-48 h. Prior to experi-
ment, DMEM complete medium was replaced withfreshly prepared assay medium. Cells were equilibrated
for 45 min at room temperature in dark. The cells were
then kept at a constant temperature of 25°C in a plate
reader (Victor, Perkin-Elmer-Wallac) for 20 min and
luminescence was measured for 5 min to obtain a basal
measurement. Measurements were made at 25°C be-
cause GloSensor-22F protein responds better at room
temperature and the signal drastically decreases at 37°C
(Additional file 4: Figure S4). Luminescence from individ-
ual wells was read either for 2, 5 or 10 s depending upon
the intensity of signal. The assay was then performed by
addition of specific ligands and recording luminescence
values for up to 2 h (see Figure 2 for a quick protocol).
Generation of stable FRET-based cAMP sensor cell line
A FRET-based cAMP sensor (TEPACVV) was kindly
provided by Prof. Kees Jalink [22]. HEK-293 cells were
transfected with TEPACVV sensor using JetPEI trans-
fection reagent followed by selection in G418 antibiotic
(400 μg/ml) containing medium. Cells were subsequently
sorted for high expression of the sensor using BD FAC-
SAria III cell sorter at Cell Imaging Core, Turku Centre
for Biotechnology. After two rounds of cell sorting, the re-
sultant sensor cell line was named as EPAC-293.
Assay methodology with EPAC-293 cells and FRET
analysis
EPAC-293 and FSHR-293 cells (50,000 cells each) were
co-cultured in 24-well plates in DMEM complete
medium. Prior to the assay, DMEM complete medium
was replaced with DMEM/F12 medium without phenol
red, supplemented with 100 μM IBMX and 0.1% BSA.
Cells were incubated at room temperature for 15 min
and subsequently transferred to Synergy H1 plate reader
(BioTek) kept at room temperature (25°C). Cells were
excited at 430/18 nm and fluorescence emission was read
at 480/18 nm and 528/18 nm. FRET ratio was calculated
by dividing fluorescent intensity values at 480 nm with in-
tensity values at 528 nm. FRET values at the start of the
experiment were set to 1.
Isolation and culturing of cortical neurons
Primary cortical neurons were isolated from newborn
Sprague-Dawley rats as previously described [46]. Briefly,
dissociated neurons were plated in Minimal Essential
Medium (MEM; Invitrogen) with 10% bovine calf
serum (HyClone), 33 mM D-glucose, 2 mM L-glutamine,
50 IU/ml penicillin and 50 μg/ml streptomycin at the
density 700,000 cells/cm2 on poly-D-Lysine (50 μM)
(Sigma) coated 24-well plates (Greiner). Proliferation of
non-neuronal cells was prevented by addition of 2.5 μM
cytosine β-D-arabinofuranoside (Sigma) from the second
day onward. Cells were maintained at 37°C with 5% CO2
until usage between 2 and 4 days in vitro. Neurons were
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glutamate (Sigma).Isolation and culturing of granulosa cells
Ovaries from 25-day-old C57BL/6 female mice were
processed for follicular puncture as described previously
[47] with some modifications. Briefly, ovaries were col-
lected into DMEM/F12 medium without phenol red
containing 50 IU/ml penicillin and 50 μg/ml strepto-
mycin followed by incubation into DMEM/F12 medium
containing 10 mM EGTA (Sigma) and 0.5M Sucrose for
30 min. Fresh DMEM/F12 medium was used to wash
and collect ovaries. Granulosa cells were collected by
puncturing the ovaries with a 25G needle 100 times in
small volume of media under a dissecting microscope.
Cells were passed through a 100 μm nylon cell strainer
(BD Biosciences) to remove cell aggregates. Cells were
centrifuged at 100 X g for 10 min and then resuspended
in DMEM/F12 medium supplemented with 1 X insulin,
transferrin, selenium solution (ITS-G; Gibco), 10% fetal
bovine serum-charcoal stripped (Sigma), 50 IU/ml penicil-
lin and 50 μg/ml streptomycin. 100,000 cells were seeded
in a 12-well plate. Granulosa cells were stimulated with re-
combinant human luteinizing hormone (rLH; Organon).Gap junction analysis and cell viability
Carbenoxolone disodium salt (CBX; Sigma) was used
as a gap junction inhibitor. Human connexin-32 plas-
mid (Cx32), C-terminally tagged with mEmerald, was
obtained from Addgene (plasmid #54054) [48] while
pcDNA 3.1 mock plasmid was purchased from Invi-
trogen. EVOS fluorescent microscope was used to ver-
ify the expression of Cx32 in cells (Additional file 3:
Figure S3). Co-cultures of GS-293 and FSHR-293 cells
were transiently transfected with Cx32 plasmid to deter-
mine the effect of connexin overexpression on cAMP
transfer.
For determining cell viability after CBX treatment,
co-cultures of GS-293 and FSHR-293 were preincu-
bated with different concentrations of CBX (25, 50, 75
and 100 μM) for 2h in assay medium. Assay medium
was then discarded, followed by washing with PBS. Cell
viability was then assessed by CellTiter AQueous non-
radioactive cell proliferation assay (Promega) following
manufacturer’s instructions. Briefly, cells were incubated
in DMEM complete medium (without phenol red) con-
taining MTS/PMS [3-(4,5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium/
phenazine methosulfate] solution for 2h (37°C, 5% CO2).
Absorbance was then read at 490 nm, which provides a
measure of cellular viability. One-way analysis of variance
(ANOVA) was used to determine statistical differences
among different samples.Cyclic AMP ELISA
A commercial cAMP ELISA kit (Cell Biolabs) was used
to determine total cAMP levels following manufacturer’s
instructions. Briefly, co-cultures of GS-293 and FSHR-293
(150,000 cells each) were seeded in 6-well plates. Prior to
ELISA, cells were incubated in assay medium (without
cAMP GloSensor reagent) containing different doses of
CBX (25, 50, 75 and 100 μM) for 1h at room temperature.
Cells were then stimulated with rFSH (200 mIU/ml) for
20 min and subsequently lysed. Cell lysates were used to
calculate cAMP values (see Figure 1A for principle of
cAMP ELISA kit). Total protein from cell lysates was
calculated using Bicinchoninic Acid (BCA) protein assay
kit (Thermo Scientific). cAMP concentrations were nor-
malized to total cellular protein.
For calculating EC50 values, FSHR-293 cells (150,000
cells) were seeded in 6-well plates. Cells were incubated
in DMEM/F12 (0.1% BSA, 100 µM IBMX) for 1h followed
by stimulation with different doses of rFSH (0.1 mIU/ml to
1000 mIU/ml) for 20 min and then lysed. Cell lysate was
similarly used to calculate cAMP concentrations. Total
cAMP values were normalized to total cellular protein.
Statistical analysis
Significance among samples was compared by one-way
ANOVA. For EC50 calculation, cAMP values were nor-
malized to percent maximal responses and curves were
fitted using four-parameter logistic curve using PRISM 6
software.
Ethical approval
All procedures were carried out according to the insti-
tutional and ethical policies of the University of Turku
and approved by the local ethics committee on animal
experimentation.
Additional files
Additional file 1: Figure S1. Determination of IBMX concentration for
CANDLES. Co-cultures of GS-293 and FSHR-293 (50,000 cells each) were
preincubated in assay medium with different concentrations of IBMX
(1, 10, 100 and 200 μM) for 45 min at room temperature and then transferred
to plate reader kept at 25°C. Luminescence was then measured and cells were
stimulated with rFSH (200 mIU/ml). Although 200 μM IBMX gives the highest
signal upon rFSH stimulation of cells, it also has a higher background
in unstimulated co-culture (red line). 100 μM IBMX also gives a high
luminescent signal upon rFSH stimulation of cells but it has lower
basal luminescence in unstimulated co-culture (green line) and was
chosen as IBMX concentration of choice to be used in CANDLES. Data
represented as mean of triplicates for one representative experiment
(± SEM; negative direction) with at least three independent repeats.
Additional file 2: Figure S2. FSH dose-response in co-culture of
EPAC-293 with FSHR-293 cells. Co-culture of EPAC-293 and FSHR-293
(50,000 cells each) were stimulated with different doses of rFSH
(10, 100, 200 and 1000 mIU/ml). Forskolin (10 μM) stimulation was
used as a positive control while unstimulated co-cultures of EPAC-293
and FSHR-293 were used as negative control. Cells were excited at
430/18 nm and changes in FRET ratio (480/528 nm) was monitored by
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http://www.biosignaling.com/content/12/1/70recording the fluorescence intensity at 480/18 and 528/18 nm. FRET
ratio was set to 1 at the beginning of experiment. Increasing doses of
rFSH (100, 200 and 1000 mIU/ml) yielded very similar changes in FRET
ratio. Data represented as mean of triplicates for one representative
experiment (± SEM; positive direction) with at least three independent
repeats.
Additional file 3: Figure S3. Cx32 expression in co-cultures of GS-293
and FSHR-293 cells. The expression of Connexin 32 tagged with mEmerald
(Cx32-mEmerald) was verified in co-cultures of GS-293 and FSHR-293 cells.
Merged phase contrast images and fluorescent images (mEmerald) are
shown. pcDNA 3.1 was used as a mock control.
Additional file 4: Figure S4. CANDLES assay responses at room
temperature (25°C) and at 37°C. Co-cultures of GS-293 (50,000 cells) and
FSHR-293 (50,000 cells) were incubated in assay medium either at 25°C
or 37°C for 45 min and then transferred to plate reader kept at the same
temperature for 20 min. Luminescence was then read and cells were
stimulated with rFSH (200 mIU/ml). The sensor protein (GloSensor 22F)
responds better at 25°C and both the signal as well as baseline drops
significantly at 37°C (also stated in Promega’s manual [49]). Data represented
as mean of triplicates for one representative experiment (± SEM) with at
least three independent repeats.
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CANDLES: Cyclic AMP iNdirect Detection by Light Emission from Sensor cells;
GPCRs: G protein-coupled receptors; cAMP: 3′,5′-cyclic adenosine
monophosphate; ATP: Adenosine triphosphate; PKA: Protein kinase A;
EPAC: Exchange protein activated by cAMP; FRET: Fluorescence resonance
energy transfer; BRET: Bioluminescence resonance energy transfer;
BSL-2: Biosafety level 2; LHCGR: Luteinizing hormone/chorionic gonadotropin
receptor; HEK-293: Human embryonic kidney-293; FSHR: Follicle-stimulating
hormone receptor; FSHR-293: HEK-293 cells stably transfected with FSHR;
GS-293: HEK293-GloSensor; EPAC-293: HEK-293 cells stably transfected with
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hormone; DMEM: Dulbecco’s modified eagle medium; CBX: Carbenoxolone;
ELISA: Enzyme-linked immunosorbent assay; GS-293-FSHR: GS-293 cells stably
transfected with human FSHR; Cx32: Connexin 32; ANOVA: Analysis of
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